Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients

Pediatr Infect Dis J. 2012 Jul;31(7):774-7. doi: 10.1097/INF.0b013e3182564ec7.

Abstract

The burden of tuberculosis after pediatric solid organ transplant or hematopoietic stem cell transplantation has not been well characterized. We report 7 pediatric cases with disseminated (4/7) or pulmonary (3/7) tuberculosis after solid organ transplant (n=6) or hematopoietic stem cell transplantation (n=1) during 26 years. The outcome was favorable in 6 patients. Isoniazid-induced hepatitis and rifampin interactions were common.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antitubercular Agents / administration & dosage
  • Child
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host
  • Male
  • Organ Transplantation / adverse effects*
  • Transplantation*
  • Treatment Outcome
  • Tuberculosis / diagnosis*
  • Tuberculosis / drug therapy
  • Young Adult

Substances

  • Antitubercular Agents